Disease Courses
Contents
Multiple sclerosis can follow relapsing or progressive patterns, and those descriptions can change over time. They are practical summaries of a person’s observed course, not separate diseases or predictions of an exact future.
Course descriptors separate phenotype from current disease activity and disability progression. A complete description states the observation period and whether clinical or MRI activity and confirmed progression were assessed.
Relapsing-remitting MS
Section titled “Relapsing-remitting MS”Relapsing-remitting MS includes distinct episodes of new inflammatory neurologic dysfunction followed by remission or recovery. Recovery may be complete, partial, or accompanied by persistent symptoms. New MRI lesions can show activity even when no clear relapse is recognized.
A clinically isolated syndrome can be the first demyelinating event. If diagnostic criteria are met, the person may be diagnosed with MS without waiting for a second clinical attack.
Secondary progressive MS
Section titled “Secondary progressive MS”Secondary progressive MS describes gradual disability worsening after an initial relapsing course. The transition is often recognized retrospectively rather than on one date. Relapses or MRI activity can still occur, so “progressive” does not automatically mean “inactive.”
Primary progressive MS
Section titled “Primary progressive MS”Primary progressive MS begins with gradual worsening rather than an initial pattern of discrete relapses and remissions. Spinal, walking, balance, or other functional changes may dominate, but alternative structural, vascular, metabolic, and degenerative causes must be considered. [1]
Activity and progression modifiers
Section titled “Activity and progression modifiers”Modern descriptors add whether disease is active, based on relapses or MRI activity, and whether progression is present over a defined period. [2] These dimensions affect monitoring and treatment discussion more than a course acronym alone.
Clinical detail
Section titled “Clinical detail”Relapse-associated worsening and progression independent of relapse can coexist. Measurement should combine history, neurologic examination, performance measures, cognition, patient-reported function, and MRI rather than infer progression from one difficult day.